Q: I’ve heard that the drug Herceptin has shown even more promise than originally thought in treating breast cancer.
A: Yes, a recent editorial in the New England Journal of Medicine reported promising news about Herceptin, an antibody used with chemotherapy for breast cancer treatment. More >>

Q: I've heard that there are new breast cancer treatments that use antibodies. How do they work?
A: Antibodies have the ability to latch on to specific bacteria, viruses or toxins in our bodies and neutralize them. More >>

Q: What is inflammatory breast cancer?
A: Inflammatory breast cancer (IBC) is a rare type of breast cancer. Fewer than five percent of women with breast cancer have IBC, thought to be caused by cancer cells blocking the lymphatic system of the breast. More >>

Q: I smoke. Am I at risk for breast cancer?
A: Yes, studies show that smoking increases your risk of developing breast and other cancers including leukemia, and cancers of the liver, stomach, pancreas and cervix. More >>

Q: I read that the American Cancer Society (ACS) is now recommending breast MRIs as well as mammograms for women at high risk for breast cancer. How do I know if I need a MRI?
A: An annual mammogram remains the best screening method for most women, but if you are at high risk, or if you have been recently diagnosed with breast cancer, MRI is an effective addition to your evaluation. More >>

Q: I heard the drug, Evista may reduce the risk for breast cancer—is that true? Who can benefit from this medication?
A: U.S. Food and Drug Administration (FDA) approved Evista (the brand name for raloxifene previously used to treat osteoporosis) to help prevent breast cancer in postmenopausal women who are at high-risk for the disease. If you think you’re at increased risk for breast cancer, you should talk with your doctor about whether or not this medication—if any—is right for you. More >>